Skip Navigation

Defense Health Agency

"On October 1, 2013, the Department of Defense established the Defense Health Agency (DHA) to manage the activities of the Military Health System. These activities include those previously managed by TRICARE Management Activity (TMA), which was disestablished on the same date. During the next several months, all TMA websites will change to reflect the new DHA. We appreciate your patience during this transition."

Testimony 2003

July 9, 2003
William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), testified on pre- and post-deployment health assessment processing of troops recently deployed to the Persian Gulf and what measures DoD took to protect Servicemembers from possible exposure to biological and chemical agents before the House Veterans’ Affairs Subcommittee on Oversight and Investigations.

June 17, 2003
Dr. David S.C. Chu, Under Secretary of Defense for Personnel and Readiness, testified on the final report of the President’s Task Force to Improve Health Care Delivery for Our Nation’s Veterans before the House Veterans’ Affairs Committee.

May 5, 2003
David Tornberg, MD, Deputy Assistant Secretary of Defense for Health Affairs, for Clinical and Program Policy and Chief Medical Officer, TRICARE Management Activity (TMA) testified on Homeland Security: Improving Public Surveillance before the House Government Reform Committee Subcommittee on National Security, Emerging Threats and International Relations

April 3, 2003
Mr. Carrato, Chief Operating Officer and Deputy Assistant Secretary of Defense for Health Plan Administration, testified on Purchasing Health Care in a Competitive Environment in front of the Senate Finance Committee. Mr. Carrato testified on behalf of William Winkenwerder, Jr., MD.

April 3, 2003
William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), provided written testimony on Fighting Fraud: Improving Information Security in front of a joint hearing of the House Committee on Financial Services Subcommittee on Financial Institutions and the Subcommittee on Oversight and Investigations

March 27, 2003
William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), testified on the status of implementation of Public Law 107-287, the Department of Veterans Affairs Emergency Preparedness Act of 2002; and VA-DOD efforts to coordinate force protection in the active duty military forces of the United States for those Service men and women who may be exposed to chemical, biological, or radiological weapons of mass destruction in theaters of conflict, before the House Committee on Veterans’ Affairs Subcommittee on Health.

March 27, 2003
William Winkenwerder, Jr. MD, Assistant Secretary of Defense (Health Affairs), testified on defense heath and matters relating to DoD budget request for FY 2004 before the House Armed Services Committee Subcommittee on Total Force.

March 25, 2003
William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), testified on protecting the health of deployed forces and lessons learned from the Persian Gulf War, before the House Committee on Government Reform Subcommittee on National Security, Emerging Threats and International Relations.

March 11, 2003
Dr. David S. C. Chu, Under Secretary of Defense (Personnel and Readiness) and William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), testified before the Senate Armed Services Committee Subcommittee on Military Personnel.

Archives